Goldman Sachs Group Inc Legend Biotech Corp Call Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$43.55 - $59.88 $1.71 Million - $2.35 Million
39,300 New
39,300 $1.92 Million
Q1 2023

May 14, 2024
BUY
$43.42 - $57.37 $434,200 - $573,700
10,000 New
10,000 $482,000
Q1 2023

May 11, 2023
BUY
$43.42 - $57.37 $434,200 - $573,700
10,000 New
10,000 $482,000

Others Institutions Holding LEGN

# of Institutions
225
Shares Held
74.3M
Call Options Held
279K
Put Options Held
350K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.68B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email